Just reported
From Iradimed's results release of 30 października 2026; its quarterly report has since been filed.
Actual
24,2M USD
+14% y/y
+18% q/q
Guided
—
No guide given
Actual
0,51 USD
+19% y/y
+24% q/q
Guided
—
No guide given
Actual
8,1M USD
+19% y/y
+27% q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Iradimed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Udziały w przychodach to szacunki za nine months ended September 30, 2026, a nie dane z raportu złożonego do regulatora.
MRidium 3870 MRI-compatible IV infusion pump system
A pump system designed to deliver medicines and fluids in the MRI room. It includes a non-magnetic pump, mobile stand, disposable tubing, and optional remote controls.
MRidium 3860+ MRI-compatible IV infusion pump system
An earlier pump system for delivering medicines and fluids during MRI procedures. IRadimed planned to stop new system sales during 2026 while continuing contracted warranty and technical support.
3880 MRI-compatible patient vital signs monitoring system
A portable monitor that tracks measures such as heart activity, blood oxygen, blood pressure, breathing, and temperature during MRI procedures and patient transport.
3600 ferromagnetic detection system with remote alarm logging unit
Equipment that detects approaching ferromagnetic metal near an MRI room and gives staff a remote screen for viewing alarms and logging items.
MRidium disposable IV tubing sets
Single-use tubing sets that connect the infusion pump to a patient and are made for different types of fluid delivery.
Pełne sprawozdania finansowe →
IRadimed makes medical equipment that can operate in the powerful magnetic fields around MRI scanners. Its intravenous (IV) pumps deliver medicines and fluids during scans, while its monitors track patients’ vital signs; both are designed to move with patients between hospital departments and the scanner. It also sells equipment that detects ferromagnetic metal near MRI rooms, along with disposable tubing, maintenance agreements, and repair services.
Zbudowane z własnych raportów spółki Iradimed Corp. składanych do amerykańskiej Komisji Papierów Wartościowych i Giełd (SEC). Liczby są takie, jak zaraportowano, a historia na akcję przeliczona na dzisiejszą bazę akcji. To opisuje firmę — nie jest poradą inwestycyjną ani rekomendacją kupna lub sprzedaży.
IRadimed sells infusion pumps designed for use beside magnetic resonance imaging (MRI) scanners to hospitals, plus patient monitors and metal detectors.
Grade A+
Pasek pod ceną pokazuje ocenę w każdym dniu, wyliczoną wyłącznie z dokumentów, które były wtedy już publiczne.
Pokazujemy 2 z 41 kwartałów historii ocen spółki Iradimed Corp.. Pozostałe 39 sięgają do listopad 2016.